Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase.

Article Details

Citation

Ferracini R, Longati P, Naldini L, Vigna E, Comoglio PM

Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase.

J Biol Chem. 1991 Oct 15;266(29):19558-64.

PubMed ID
1655790 [ View in PubMed
]
Abstract

The MET proto-oncogene encodes a transmembrane tyrosine kinase receptor for HGF (p190MET). In this work, p190MET was immunoprecipitated, allowed to phosphorylate in the presence of [gamma-32P]ATP, and digested with trypsin. A major phosphopeptide was purified by reverse phase chromatography. The phosphorylated tyrosine was identified as residue 1235 (Tyr1235) by Edman covalent radiosequencing. A synthetic peptide derived from the corresponding MET sequence was phosphorylated by p190MET in an in vitro assay and coeluted in reverse phase chromatography. Tyr1235 lies within the tyrosine kinase domain of p190MET, within a canonical tyrosine autophosphorylation site that shares homology with the corresponding region of the insulin, CSF-1 and platelet-derived growth factor receptors, and of p60src and p130gag-fps. The p190MET kinase is constitutively phosphorylated on tryosine in a gastric carcinoma cell line (GTL16), due to the amplification and overexpression of the MET gene. Metabolic labeling of GTL-16 cells with [32P]orthophosphate followed by immunoprecipitation and tryptic phosphopeptide mapping of p190MET showed that Tyr1235 is a major site of tyrosine phosphorylation in vivo as well. Since phosphorylation activates p190MET kinase, we propose a regulatory role for Tyr1235.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Hepatocyte growth factor receptorP08581Details